This study will create a prospective registry of consecutive patients with Atrial Fibrillation (Afib) considered for cardioversion treatment to document up-to-date practice of in-hospital treatment, with a focus on the characterization of type of Afib, as well as on treatments applied (drugs, devices, interventions and their combinations), and associated complications within 60 days after enrollment.
Study Type
OBSERVATIONAL
Enrollment
4,658
Cardiovascular Disease History of Participants Presenting With Atrial Fibrillation at Baseline (Admission)
Time frame: Baseline (time of admission)
Co-Morbidity in Participants Presenting With Atrial Fibrillation at Baseline (Admission)
Time frame: Baseline (time of admission)
Clinical Type of Atrial Fibrillation at Baseline (Admission)
Time frame: Baseline (time of admission)
Treatments Utilized for Participants for Atrial Fibrillation
Time frame: At time of Treatment (up to 1 day from admission)
Percentage of Participants Who Had a Successful Electrical or Pharmacological Cardioversion
Pharmacological cardioversion was considered successful if sinus rhythm or atrial rhythm was obtained within 24 hours after its initiation. Electrical cardioversion was considered successful if sinus rhythm was obtained and maintained for at least 10 minutes after the last shock was administered.
Time frame: At time of treatment (up to 1 day from admission)
Complications Experienced by Participants Who Underwent a Cardioversion for Treatment of Atrial Fibrillation
Time frame: up to 60 days from day of treatment (cardioversion)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.